Tumor cell macromolecules

Tumor cell macromolecules is a broad, non-specific term used in pharmacology to describe the collective set of large biological molecules—including DNA, RNA, and proteins—within a cancer cell that serve as the site of action for certain therapeutic agents (DrugBank, 2024). This designation is typically applied to cytotoxic drugs, such as alkylating agents or specific dyes like rose bengal sodium, which do not target a single specific receptor or enzyme but instead interact with multiple cellular components to induce cell death (PubMed, PMID: 25633795). Historically, many classical chemotherapy agents were described as interacting with these macromolecules to inhibit cell division and induce apoptosis by forming covalent bonds or cross-links (National Cancer Institute, 2023). Because these targets are present in both cancerous and healthy cells, drugs directed at tumor cell macromolecules often exhibit a narrow therapeutic index and significant systemic side effects, such as bone marrow suppression (StatPearls, 2023). In modern oncology, this term is largely considered a legacy or placeholder category, as research shifts toward identifying specific molecular drivers and receptors for targeted therapy (NIH, 2024).

Other names

Neoplastic cell macromoleculesCancer cell macromoleculesTumor-associated macromolecules

Non-specific alkylation of DNA, RNA, and proteins; cross-linking of nucleic acids; and induction of oxidative stress or physical disruption of cellular organelles.